Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy
- PMID: 2562959
- PMCID: PMC303650
- DOI: 10.1172/JCI113845
Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy
Abstract
Patients with essential hypertension show an increase in vascular resistance. It is unclear whether this is caused by structural changes in the arterial wall or by hyperresponsiveness of vascular smooth muscle to endogenous alpha adrenergic agonists. Using the dorsal hand vein compliance technique we compared the changes in diameter of superficial veins in response to phenylephrine, an alpha 1 adrenergic receptor agonist, and to nitroglycerin, a venorelaxant, in patients with essential hypertension and in normotensive subjects. The dose of phenylephrine that produced 50% of maximal venoconstriction (ED50) in the hypertensive subjects was 257 ng/min (geometric mean; log mean +/- SD was 2.41 +/- 0.54). In the control subjects the ED50 was 269 ng/min (geometric mean; log mean was 2.43 +/- 0.43). Maximal response (Emax) for phenylephrine was 84 +/- 13% in the hypertensive subjects and 90 +/- 6% in the control subjects. Differences in the group means of the ED50 (P = 0.92) or the Emax (P = 0.27) were not significant. There were no significant differences in the ED50 (P = 0.54) or the Emax (P = 0.08) for nitroglycerin between the two groups. These results show no evidence for a generalized change in alpha adrenergic responsiveness in hypertension and support the concept that increased blood pressure responses to alpha adrenergic stimulation in hypertensives are due to structural and geometric changes in the arterial wall rather than to an increased responsiveness of postsynaptic alpha adrenergic receptors. The phenylephrine studies were repeated in seven hypertensive patients during treatment with prazosin, an alpha 1 adrenergic antagonist. The mean dose ratio of the shift in phenylephrine ED50 (ED50 during prazosin therapy/ED50 before prazosin therapy) was 6.1. This indicates that small doses of prazosin (1-2 mg) cause significant in vivo shifts in the dose-response relationship of alpha adrenergic agonists. The dorsal hand vein compliance technique is useful in detecting systemic effects of alpha adrenergic antagonists.
Similar articles
-
Decreased responsiveness of superficial hand veins to phenylephrine in black normotensive males.J Cardiovasc Pharmacol. 1990 Aug;16(2):177-81. doi: 10.1097/00005344-199008000-00001. J Cardiovasc Pharmacol. 1990. PMID: 1697371
-
Normal responsiveness of superficial hand veins to alpha- and beta-adrenergic stimuli in allergic asthma: effects of terbutaline and prednisolone on beta-adrenergic responsiveness.J Allergy Clin Immunol. 1990 Nov;86(5):714-25. doi: 10.1016/s0091-6749(05)80175-7. J Allergy Clin Immunol. 1990. PMID: 1977786
-
Responsiveness of superficial hand veins to alpha-adrenoceptor agonists in insulin-dependent diabetic patients.Clin Sci (Lond). 1992 Feb;82(2):163-8. doi: 10.1042/cs0820163. Clin Sci (Lond). 1992. PMID: 1347259
-
Selective alpha 1-adrenergic antagonists: therapeutically relevant antihypertensive agents.Am J Cardiol. 1984 Jan 27;53(3):16A-20A. doi: 10.1016/0002-9149(84)90829-4. Am J Cardiol. 1984. PMID: 6141721 Review.
-
New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance.Am Heart J. 1988 Jul;116(1 Pt 1):133-62. doi: 10.1016/0002-8703(88)90261-x. Am Heart J. 1988. PMID: 2899387 Review.
Cited by
-
Alpha-Adrenergic Mechanisms in the Cardiovascular Hyperreactivity to Norepinephrine-Infusion in Essential Hypertension.Front Endocrinol (Lausanne). 2022 Jul 22;13:824616. doi: 10.3389/fendo.2022.824616. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35937820 Free PMC article.
-
Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1.J Clin Invest. 1994 Oct;94(4):1359-64. doi: 10.1172/JCI117470. J Clin Invest. 1994. PMID: 7929810 Free PMC article. Clinical Trial.
-
Comparison of the effects of nadolol and bisoprolol on noradrenaline-evoked venoconstriction in man in vivo.Br J Clin Pharmacol. 1998 Mar;45(3):271-6. doi: 10.1046/j.1365-2125.1998.00683.x. Br J Clin Pharmacol. 1998. PMID: 9517371 Free PMC article. Clinical Trial.
-
Alpha-adrenoceptor gene variants and autonomic nervous system function in a young healthy Japanese population.J Hum Genet. 2007;52(1):28. doi: 10.1007/s10038-006-0076-3. Epub 2006 Oct 31. J Hum Genet. 2007. PMID: 17075692
-
Clinical pharmacology, physiology and pathophysiology of superficial veins--2.Br J Clin Pharmacol. 1994 Oct;38(4):289-305. doi: 10.1111/j.1365-2125.1994.tb04357.x. Br J Clin Pharmacol. 1994. PMID: 7833218 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical